Skip to content

MaPharma: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MaPharma

BE 0799.383.730
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 compared with 2023filed annual accounts (NBB)
Net result for the year
-€33,660
2023 · -€73,223+€39,562
Equity
-€104,883
2023 · -€71,223-€33,660
Cash
€10,448
2023 · €1,523+€8,925
Balance sheet total
€256,730
2023 · €276,637-€19,907

Largest movements

2023 to 2024
Assets
  • Receivables within one year -€10,665

    down €10,665 (-19.5%), from €54,625 to €43,960

  • Tangible fixed assets -€9,340

    down €9,340 (-15.9%), from €58,700 to €49,360

    of which Plant, machinery and equipment: -€5,490

  • Cash +€8,925

    up €8,925 (+586%), from €1,523 to €10,448

    mainly Other debts (+€22,615) and Debts after one year (+€15,102)

  • Stocks and contracts -€8,827

    down €8,827 (-5.5%), from €161,789 to €152,962

Equity and liabilities
  • Profit (loss) carried forward -€33,660

    down €33,660 (-46.0%), from -€73,223 to -€106,883

  • Other debts +€22,615

    up €22,615 (+151%), from €14,965 to €37,581

  • Current portion of long-term debt -€15,203

    down €15,203 (-37.4%), from €40,672 to €25,468

  • Debts after one year +€15,102

    up €15,102 (+9.8%), from €153,777 to €168,879

    of which Other amounts payable: +€40,000

  • Trade debts -€10,498

    down €10,498 (-8.1%), from €129,279 to €118,781

Income statement
  • Gross operating margin +€42,886

    up €42,886 (+1,619%), from €2,649 to €45,535

  • Purchases and services -€8,209

    down €8,209 (-1.7%), from €489,138 to €480,928

  • Financial charges -€3,662

    down €3,662 (-34.0%), from €10,759 to €7,097

    of which Financial charges: -€3,709

  • Depreciation +€1,740

    up €1,740 (+22.9%), from €7,600 to €9,340

  • Staff costs +€732

    up €732 (+1.4%), from €53,218 to €53,950

From the 2023 result to the 2024 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2023 -€73,223
Gross operating margin +€42,886
Staff costs -€732
Depreciation -€1,740
Other operating charges -€137
Other operating items -€4,116
Financial income -€1
Financial charges +€3,662
Taxes -€259
Result 2024 -€33,660
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2023 to 2024

Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€9,026
Investment €0
Financing -€101
Cash 2023 €1,523
Net result for the year -€33,660
Depreciation +€9,340
Stocks and contracts +€8,827
Receivables within one year +€10,665
Trade debts -€10,498
Tax, wage and social debts +€1,737
Other debts +€22,615
Debts after one year +€15,102
Current portion of long-term debt -€15,203
Cash 2024 €10,448
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2023 2024 Change %
Total assets 20/58 €276,637 €256,730 -€19,907 -7.2%
Fixed assets 21/28 €58,700 €49,360 -€9,340 -15.9%
Tangible fixed assets 22/27 €58,700 €49,360 -€9,340 -15.9%
Plant, machinery and equipment 23 €47,633 €42,143 -€5,490 -11.5%
Furniture and vehicles 24 €11,067 €7,217 -€3,850 -34.8%
Current assets 29/58 €217,937 €207,370 -€10,567 -4.8%
Stocks and contracts in progress 3 €161,789 €152,962 -€8,827 -5.5%
Stocks 30/36 €161,789 €152,962 -€8,827 -5.5%
Amounts receivable within one year 40/41 €54,625 €43,960 -€10,665 -19.5%
Trade receivables 40 €54,625 €43,960 -€10,665 -19.5%
Cash at bank and in hand 54/58 €1,523 €10,448 +€8,925 +586%
Total equity and liabilities 10/49 €276,637 €256,730 -€19,907 -7.2%
Equity 10/15 -€71,223 -€104,883 -€33,660 -47.3%
Contributions 10/11 €2,000 €2,000 = 0.0%
Profit (loss) carried forward 14 -€73,223 -€106,883 -€33,660 -46.0%
Amounts payable 17/49 €347,860 €361,613 +€13,753 +4.0%
Amounts payable after more than one year 17 €153,777 €168,879 +€15,102 +9.8%
Financial debts 170/4 €78,777 €53,879 -€24,898 -31.6%
Other amounts payable 178/9 €75,000 €115,000 +€40,000 +53.3%
Amounts payable within one year 42/48 €194,083 €192,734 -€1,349 -0.7%
Current portion of amounts payable after more than one year 42 €40,672 €25,468 -€15,203 -37.4%
Trade debts 44 €129,279 €118,781 -€10,498 -8.1%
Suppliers 440/4 €129,279 €118,781 -€10,498 -8.1%
Taxes, remuneration and social security 45 €9,167 €10,904 +€1,737 +19.0%
Taxes 450/3 €1,468 €1,234 -€234 -15.9%
Remuneration and social security 454/9 €7,699 €9,670 +€1,971 +25.6%
Other amounts payable 47/48 €14,965 €37,581 +€22,615 +151%
Goods, raw materials, services and sundry goods 60/61 €489,138 €480,928 -€8,209 -1.7%
Remuneration, social security and pensions 62 €53,218 €53,950 +€732 +1.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,600 €9,340 +€1,740 +22.9%
Other operating charges 640/8 €1,910 €2,047 +€137 +7.2%
Non-recurring operating charges 66A €2,404 €6,520 +€4,116 +171%
Gross operating margin 9900 €2,649 €45,535 +€42,886 +1,619%
Operating profit (loss) 9901 -€62,483 -€26,322 +€36,161 +57.9%
Financial income 75/76B €19 €19 -€1 -4.7%
Recurring financial income 75 €19 €19 -€1 -4.7%
Financial charges 65/66B €10,759 €7,097 -€3,662 -34.0%
Recurring financial charges 65 €10,759 €7,050 -€3,709 -34.5%
Non-recurring financial charges 66B - €47 +€47
Profit (loss) for the period before taxes 9903 -€73,223 -€33,401 +€39,822 +54.4%
Income taxes 67/77 - €259 +€259
Profit (loss) for the period 9904 -€73,223 -€33,660 +€39,562 +54.0%
Profit (loss) for the period to be appropriated 9905 -€73,223 -€33,660 +€39,562 +54.0%

Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.